San Francisco, California, United States
Allison Duettmann is the president and CEO of Foresight Institute, a leading San Francisco non-profit founded in 1986 to advance frontier technology for the benefit of life. She directs the institute’s AI, longevity biotechnology, molecular nanotechnology, and neurotechnology grants, fellowships, and prizes. She founded Existentialhope.com, co-initiated Foresight's AI Safety Grant Program, The Norm Hardy Prize for Computer Security, and The Longevity Prize. She advises companies and projects, such as the Filecoin Foundation, Lionheart VC, and Neuromatch, and is on the Biomarker of Aging Consortium Steering Committee. She holds an MS in Philosophy & Public Policy from the London School of Economics, focusing on AI philosophy. Bio and selected appearances: https://foresight.org/our-team/allison-duettmann-president-ceo/ More active on https://twitter.com/allisondman
Founded in 1986, Foresight Institute supports the beneficial development of high-impact technology to make great futures more likely. We focus on science and technology that is too ambitious for legacy institutions to support, such as secure AI, longevity biotechnology, neurotechnology, nanotechnology, and space. We offer grants, fellowships, prizes, workshops, and seminars in these areas. https://foresight.org
https://www.agingconsortium.org